CD276 and neoplasm: This is relevant for biomarker development for B7-H3 targeting since if the threshold of target expression necessary for drug response is low, biomarker analyses could be performed on archival tissue, and patients may be spared of the need for invasive, fresh CRPC tumour biopsies.